Trial intelligence / Profile preview

V0498 ibuprofen lozenges vs placebo in acute sore throat pain

2012-004423-20Phase 3Completed

Sponsor
Pierre Fabre Laboratories
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in acute pharyngitis and tonsillopharyngitis comparing V0498 ibuprofen lozenges with Placebo lozenges (2 arms). Primary endpoint: Total Pain Relief (TOTPAR). Started Nov 2012; status: completed.

02

Drugs

ibuprofen
03

Conditions

acute pharyngitistonsillopharyngitis

Beyond the preview

Go deeper on 2012-004423-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-004423-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call